XML 11 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
ATM Equity Offering Program
Common Stock
Common Stock
ATM Equity Offering Program
Additional Paid-In Capital
Additional Paid-In Capital
ATM Equity Offering Program
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2022 $ 56,084   $ 1   $ 500,827   $ (251) $ (444,493)
Beginning balance, (in shares) at Dec. 31, 2022     14,215,302          
Issuance of common stock, net of issuance costs   $ 274       $ 274    
Issuance of common stock (in shares)       106,781        
Vesting of restricted stock units, (in shares)     37,131          
Stock-based compensation 2,175       2,175      
Unrealized (gain) loss on available-for-sale marketable securities 101           101  
Net loss (5,279)             (5,279)
Ending balance at Mar. 31, 2023 53,355   $ 1   503,276   (150) (449,772)
Ending balance, (in shares) at Mar. 31, 2023     14,359,214          
Beginning balance at Dec. 31, 2022 56,084   $ 1   500,827   (251) (444,493)
Beginning balance, (in shares) at Dec. 31, 2022     14,215,302          
Net loss (35,520)              
Ending balance at Sep. 30, 2023 27,725   $ 1   507,789   (55) (480,010)
Ending balance, (in shares) at Sep. 30, 2023     14,614,890          
Beginning balance at Mar. 31, 2023 53,355   $ 1   503,276   (150) (449,772)
Beginning balance, (in shares) at Mar. 31, 2023     14,359,214          
Issuance of common stock, net of issuance costs   518       518    
Issuance of common stock (in shares)       168,000        
Issuance of common stock under 2018 ESPP 91       91      
Issuance of common stock under 2018 ESPP (in Shares)     41,497          
Vesting of restricted stock units, (in shares)     26,766          
Stock-based compensation 2,247       2,247      
Unrealized (gain) loss on available-for-sale marketable securities 14           14  
Net loss (15,456)             (15,456)
Ending balance at Jun. 30, 2023 40,769   $ 1   506,132   (136) (465,228)
Ending balance, (in shares) at Jun. 30, 2023     14,595,477          
Fees related to the ATM offering program   $ (48)       $ (48)    
Vesting of restricted stock units, (in shares)     19,413          
Stock-based compensation 1,705       1,705      
Unrealized (gain) loss on available-for-sale marketable securities 81           81  
Net loss (14,782)             (14,782)
Ending balance at Sep. 30, 2023 27,725   $ 1   507,789   (55) (480,010)
Ending balance, (in shares) at Sep. 30, 2023     14,614,890          
Beginning balance at Dec. 31, 2023 $ 28,398 [1]   $ 2   512,773   (24) (484,353)
Beginning balance, (in shares) at Dec. 31, 2023 16,784,969   16,784,969          
Repurchase of early exercised shares, (in shares)     (3,336)          
Vesting of restricted stock units, (in shares)     5,014          
Stock-based compensation $ 1,394       1,394      
Unrealized (gain) loss on available-for-sale marketable securities (14)           (14)  
Net loss (5,790)             (5,790)
Ending balance at Mar. 31, 2024 23,988   $ 2   514,167   (38) (490,143)
Ending balance, (in shares) at Mar. 31, 2024     16,786,647          
Beginning balance at Dec. 31, 2023 $ 28,398 [1]   $ 2   512,773   (24) (484,353)
Beginning balance, (in shares) at Dec. 31, 2023 16,784,969   16,784,969          
Net loss $ (17,550)              
Ending balance at Sep. 30, 2024 $ 14,144   $ 2   516,006   39 (501,903)
Ending balance, (in shares) at Sep. 30, 2024 16,850,350   16,850,350          
Beginning balance at Mar. 31, 2024 $ 23,988   $ 2   514,167   (38) (490,143)
Beginning balance, (in shares) at Mar. 31, 2024     16,786,647          
Issuance of common stock under 2018 ESPP 68       68      
Issuance of common stock under 2018 ESPP (in Shares)     52,494          
Vesting of restricted stock units, (in shares)     8,481          
Stock-based compensation 974       974      
Unrealized (gain) loss on available-for-sale marketable securities 3           3  
Net loss (5,279)             (5,279)
Ending balance at Jun. 30, 2024 19,754   $ 2   515,209   (35) (495,422)
Ending balance, (in shares) at Jun. 30, 2024     16,847,622          
Vesting of restricted stock units, (in shares)     2,728          
Stock-based compensation 797       797      
Unrealized (gain) loss on available-for-sale marketable securities 74           74  
Net loss (6,481)             (6,481)
Ending balance at Sep. 30, 2024 $ 14,144   $ 2   $ 516,006   $ 39 $ (501,903)
Ending balance, (in shares) at Sep. 30, 2024 16,850,350   16,850,350          
[1] The balance sheet as of December 31, 2023 is derived from the audited financial statements as of that date.